Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks

Lasers in Surgery and Medicine

Volumn 40, Issue 1, 2008, Pages 1-5

  Phung, Thuy L ^a   Oble, Darryl A ^b,d   Jia, Wangcun ^c   Benjamin, Laura E ^a   Mihm Jr , Martin C ^b   Nelson, J Stuart ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Och Spine at New York Presbyterian Hospitals

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; RAPAMYCIN;

DRUG EFFECT; DRUG EFFICACY; EDEMA; HUMAN; HYPOXIA; INFLAMMATION; LASER COAGULATION; NEVUS FLAMMEUS; NONHUMAN; PRIORITY JOURNAL; PULSED DYE LASER; PURPURA; REVASCULARIZATION; SHORT SURVEY; TREATMENT OUTCOME; WOUND HEALING;

COMBINED MODALITY THERAPY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LASER THERAPY; PHOTOMICROGRAPHY; PORT-WINE STAIN; SIROLIMUS; SKIN; TREATMENT OUTCOME; WOUND HEALING;

EID: 38949157092     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20599     Document Type: Short Survey

References (14)

1. Anderson RR, Parrish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-527.
2. van der Horst CMAM, Koster PHL, deBorgie CAJM, Bossuyt PMM, van Gemert MJC. Effect of timing of treatment of port-wine stains with the flash-lamp-pumped pulsed dye laser. N Engl J Med 1998;338:1028-1033.
3. Morelli JG, Weston WL, Huff JC, Yohn JJ. Initial lesion size as a predictive factor in determining the response of port-wine stains in children treated with the pulsed dye laser. Arch Pediatr Adolesc Med 1995;149:1142-1144.
4. Lanigan SW. Port-wine stains unresponsive to pulsed dye laser: Explanations and solutions. Br J Dermatol 1998;139:173-177.
5. Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007;12:9-22.
6. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor. Nat Med 2002;8:128-135.
7. Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 2003;4:147-158.
8. Mayerhofer M, Valent P, Sperr WR, Griffin JD, Sillaber C. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 2002;100:3767-3775.
9. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005;438:932-936.
10. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438:967-974.
11. Jain RK. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005;307:58-62.
12. Orten SS, Waner M, Flock S. Port wine stains: An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surgery 1996;122:1174-1179.
13. Mork NJ, Austad J, Helsing P. Do port wine stains recur after successful treatment with pulsed dye laser? J Eur Acad Dermatol Venereol 1998;11:S142-S143.
14. Huikeshoven M, Koster PHL, de Borgie CAJM, Beek J, van Gemert MJC, van der Horst CMAM. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med 2007;356:1235-1240.